I like your thoughts. Easiest way to boost revenue and more than offset any decline if the AstraZeneca proposal eventuates. Something is getting more probable and that is the API /Sigma merger will be on the table again if more pharmaceutical companies go direct.
Ageing population... Sigma and the other major asx listed wholesalers are all long term investment opportunities. The current share price presents a great opportunity that won't last long if more SMSF investors catch on. It is a stock that will pay reliable dividends and from where it stands now there is substantial capital growth prospects.
Ann: Change in substantial holding, page-3
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.89 |
Change
0.110(3.96%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.82 | $2.92 | $2.76 | $22.11M | 7.733M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 509791 | $2.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.90 | 226186 | 6 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
